Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CMS Energy
CMS
$21.4B
| $5.23M | ﹤0.01% |
88,491
+14,562
| +20% | +$906K |
|
3902
CALL
indie Semiconductor
INDI
$799M
| $5.23M | ﹤0.01% |
+529,200
| New | +$5.05M |
|
3903
CALL
Acadia Pharmaceuticals
ACAD
$5.02B
| $5.23M | ﹤0.01% |
214,300
-248,700
| -54% | -$5.61M |
|
|
CELL
3904
PUT
DELISTED
PhenomeX Inc. Common Stock
CELL
| $5.22M | ﹤0.01% |
116,500
+15,400
| +15% | +$714K |
|
|
NTP
3905
CALL
DELISTED
Nam Tai Property Inc.
NTP
| $5.22M | ﹤0.01% |
188,300
+108,000
| +134% | +$2.26M |
|
3906
Essex Property Trust
ESS
$18.3B
| $5.22M | ﹤0.01% |
17,384
-7,321
| -30% | -$2.16M |
|
|
EVRI
3907
CALL
DELISTED
Everi Holdings
EVRI
| $5.21M | ﹤0.01% |
208,800
-952,700
| -82% | -$18M |
|
3908
Ameren
AEE
$29.4B
| $5.2M | ﹤0.01% |
65,012
+10,830
| +20% | +$907K |
|
3909
PUT
Ocular Therapeutix
OCUL
$2.28B
| $5.2M | ﹤0.01% |
367,000
+95,800
| +35% | +$1.46M |
|
3910
PUT
iShares Core US Aggregate Bond ETF
AGG
$138B
| $5.2M | ﹤0.01% |
45,100
+2,900
| +7% | +$332K |
|
3911
PUT
AvePoint
AVPT
$2.96B
| $5.2M | ﹤0.01% |
424,400
-41,800
| -9% | -$456K |
|
|
PRTY
3912
DELISTED
Party City Holdco Inc.
PRTY
| $5.2M | ﹤0.01% |
557,219
-567,378
| -50% | -$4.63M |
|
3913
CALL
Vanguard World Funds Extended Duration ETF
EDV
$3.52B
| $5.2M | ﹤0.01% |
38,400
-1,300
| -3% | -$168K |
|
3914
CALL
Robert Half
RHI
$4.64B
| $5.2M | ﹤0.01% |
58,400
+19,500
| +50% | +$1.7M |
|
|
KRA
3915
CALL
DELISTED
Kraton Corporation
KRA
| $5.19M | ﹤0.01% |
160,800
+127,500
| +383% | +$4.5M |
|
3916
PUT
Arcturus Therapeutics
ARCT
$432M
| $5.19M | ﹤0.01% |
153,300
-28,200
| -16% | -$955K |
|
3917
Akamai
AKAM
$15.4B
| $5.19M | ﹤0.01% |
44,473
-32,159
| -42% | -$3.59M |
|
3918
PUT
Coursera
COUR
$1.71B
| $5.17M | ﹤0.01% |
+130,800
| New | +$5.63M |
|
3919
Ovintiv
OVV
$17.9B
| $5.17M | ﹤0.01% |
164,268
+144,688
| +739% | +$3.89M |
|
|
MDP
3920
PUT
DELISTED
Meredith Corporation
MDP
| $5.17M | ﹤0.01% |
119,000
+100,500
| +543% | +$3.57M |
|
3921
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.6B
| $5.16M | ﹤0.01% |
111,500
-145,500
| -57% | -$6.4M |
|
|
ANAT
3922
DELISTED
American National Group, Inc. Common Stock
ANAT
| $5.15M | ﹤0.01% |
34,694
+22,702
| +189% | +$3.04M |
|
|
MRTX
3923
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.15M | ﹤0.01% |
31,900
-65,900
| -67% | -$10.6M |
|
3924
Western Alliance Bancorporation
WAL
$8.57B
| $5.14M | ﹤0.01% |
55,368
+12,862
| +30% | +$1.27M |
|
3925
Deckers Outdoor
DECK
$12B
| $5.13M | ﹤0.01% |
80,154
-69,786
| -47% | -$3.94M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.